ICON Creates New Global Innovation Hub in Ireland
News Feb 05, 2015
ICON plc has announced a new global innovation hub which will create 200 new jobs in Ireland. The hub will foster the development of new technologies and clinical trial processes that will enable faster access to large volumes of clinical data and will enable clinical trial personnel to derive better insights from the data. The 200 new jobs will include roles in IT, Data Analytics, Clinical Science, Project Management, Finance and Human Resources.
This project has been part-funded by the Department of Jobs, Enterprise and Innovation through Enterprise Ireland.
Commenting on the announcement, Ciaran Murray, Chief Executive Officer, ICON plc, said: “Since our foundation in Dublin in 1990, ICON has grown to become a global leader in clinical research, employing 11,000 highly-skilled professionals in 40 countries. We have successfully built relationships with all of the world’s top biopharma companies and have been at the forefront of innovation in the design and conduct of global clinical trials. As innovation plays an increasingly important role in improving the outcomes of clinical trials, we are excited to reinforce our commitment to that goal by locating our global innovation hub in Ireland, one of the leading R&D and innovation centres in the world.”
The Minister for Jobs, Enterprise and Innovation, Richard Bruton TD said: “As I have said from the start of the Action Plan for Jobs process in 2012, our key aim is to create a powerful engine of Irish enterprise alongside the strong multinational sector we have built up. ICON is a great example of what we are trying to achieve - an Irish company, operating in 40 countries around the world, delivering cutting edge services to some of the world’s biggest businesses, and employing increasing numbers of people in Ireland. Today’s announcement that ICON is creating an extra 200 jobs in Ireland - split roughly evenly between Dublin and Limerick - which will take its total employment to 1200 here, is a huge boost and a great example of what is possible from companies like this. I look forward to working with Ciaran and the team as they continue to grow”.
Julie Sinnamon, CEO Enterprise Ireland added: “Congratulations is due to ICON on their tremendous success to date. Enterprise Ireland is committed to working with companies like ICON to help them innovate and internationalize technologies to support the design, implementation, management and interpretation of clinical trials throughout the world. I warmly welcome this exciting new investment which will expand Ireland’s capabilities in the field of data analytics and ‘Big Data’ management in the Life Sciences sector, and wish ICON continued success for the future”.
Cancer Cells’ Energy Source Blocked by Natural CompoundNews
Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.READ MORE
Methane Hydrate Formation Studied Using Novel MicroreactorNews
Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.READ MORE